PATENT CLAIM ANALYSIS

Application Number: 16030729
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["514", "330000"]

Abstract:
Compounds are provided that are modulators of the C5a receptor. The compounds are substituted piperidines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activtation of C5a receptors.

Claim (Index 33):
The method of  claim 32 , wherein the disease or disorder is selected from the group consisting of myocardial infarction, coronary thrombosis, vascular occlusion, post-surgical vascular reocclusion, artherosclerosis, traumatic central nervous system injury and ischemic heart disease.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 95.0
- Lexical Diversity: 1.34483
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12643229', '15991747', '15991703', '13806339', '15908508']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8024763594597738
- 35 USC 102 Novelty (BERT): 0.5449618691662466
- Combined Prediction Score: 0.776724910430421
- Mean Citation Score: 345.740594
- Max Citation Score: 404.33044
- Similarity Product: 221.5620103639484

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test